{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:22:58Z","timestamp":1794565378561,"version":"4.9.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>\n                    Statin use decreases the risk of decompensation and mortality in patients with cirrhosis due to hepatitis C virus (HCV). Whether this beneficial effect can be extended to cirrhosis in the general population or cirrhosis due to other causes, such as hepatitis B virus (HBV) infection or alcohol, remains unknown. Statin use also decreases the risk of hepatocellular carcinoma (HCC) in patients with chronic HBV and HCV infection. It is unclear whether the effect can be observed in patients with pre\u2010existing cirrhosis. The goal of this study was to determine the effect of statin use on rates of decompensation, mortality, and HCC in HBV\u2010, HCV\u2010, and alcohol\u2010related cirrhosis. Patients with cirrhosis were identified from a representative cohort of Taiwan National Health Insurance beneficiaries from 2000 to 2013. Statin users, defined as having a cumulative defined daily dose (cDDD) \u226528, were selected and served as the case cohort. Statin nonusers (&lt;28 cDDD) were matched through propensity scores. The association between statin use and risk of decompensation, mortality, and HCC were estimated. A total of 1350 patients with cirrhosis were enrolled. Among patients with cirrhosis, statin use decreased the risk of decompensation, mortality, and HCC in a dose\u2010dependent manner (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    for trend &lt;0.0001, &lt;0.0001, and 0.009, respectively). Regression analysis revealed a lower risk of decompensation among statin users with cirrhosis due to chronic HBV (adjusted hazard ratio [HR], 0.39; 95% confidence interval [CI], 0.25\u20100.62) or HCV infection (HR, 0.51; 95% CI, 0.29\u20100.93). The lowered risk of decompensation was of borderline significance among statin users with alcohol\u2010related cirrhosis (HR, 0.69; 95% CI, 0.45\u20101.07).\n                    <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>\n                    : Statin use decreases the decompensation rate in both HBV\u2010 and HCV\u2010related cirrhosis. Of borderline significance is a decreased decompensation rate in alcohol\u2010related cirrhosis. (H\n                    <jats:sc>epatology<\/jats:sc>\n                    2017;66:896\u2013907).\n                  <\/jats:p>","DOI":"10.1002\/hep.29172","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T05:06:42Z","timestamp":1489986402000},"page":"896-907","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":109,"title":["Statins decrease the risk of decompensation in hepatitis B virus\u2013 and hepatitis C virus\u2013related cirrhosis: A population\u2010based study"],"prefix":"10.1097","volume":"66","author":[{"given":"Fu\u2010Ming","family":"Chang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Yuanshan Branch,Taipei Veterans General Hospital,I\u2010Lan,Taiwan"},{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen\u2010Po","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"},{"name":"Endoscopy Center for Diagnosis and Treatment,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Institute of Brain Science,National Yang\u2010Ming University,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2010Chu","family":"Lang","sequence":"additional","affiliation":[{"name":"Institute of Hospital and Health Care Administration,National Yang\u2010Ming University,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia\u2010Fen","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"},{"name":"Institute of Brain Science,National Yang\u2010Ming University,Taipei,Taiwan"},{"name":"Department of Psychiatry,Taipei Veterans General Hospital,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2010Chih","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"},{"name":"Endoscopy Center for Diagnosis and Treatment,Taipei Veterans General Hospital,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa\u2010Yauh","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching\u2010Liang","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology,Taipei Veterans General Hospital,Taipei,Taiwan"},{"name":"Department of Medicine,National Yang\u2010Ming University,Taipei,Taiwan"},{"name":"Institute of Brain Science,National Yang\u2010Ming University,Taipei,Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"hep29172-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"hep29172-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1289","article-title":"A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension","volume":"11","year":"2005","journal-title":"Nat Med"},{"key":"hep29172-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis\u2014current status and future directions","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"hep29172-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho\u2010kinase and activation of endothelial nitric oxide synthase","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"hep29172-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","article-title":"Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats","volume":"46","year":"2007","journal-title":"J Hepatol"},{"key":"hep29172-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s10620-014-3179-2","article-title":"Statin use in patients with cirrhosis: a retrospective cohort study","volume":"59","year":"2014","journal-title":"Dig Dis Sci"},{"key":"hep29172-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2015.10.007","article-title":"Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C\u2010related compensated cirrhosis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ajg.2016.179","article-title":"Statins reduce the risk of cirrhosis and its decompensation in chronic hepatitis B patients: a nationwide cohort study","volume":"111","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"hep29172-bib-0011-20241017","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","year":"2003","journal-title":"Clin Cancer Res"},{"key":"hep29172-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection","volume":"30","year":"2012","journal-title":"J Clin Oncol"},{"key":"hep29172-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"hep29172-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2015.07.006","article-title":"Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"hep29172-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2369-13-43","article-title":"Long\u2010term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan","volume":"13","year":"2012","journal-title":"BMC Nephrol"},{"key":"hep29172-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2012.12.001","article-title":"Increased incidence of orthopedic fractures in cirrhotic patients: a nationwide population\u2010based study","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep29172-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/j.gastro.2010.06.067","article-title":"Histamine2\u2010receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"hep29172-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee\u2010time bias","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"hep29172-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1940-6207.CAPR-13-0189","article-title":"A randomized, double\u2010blind, placebo\u2010controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology","volume":"7","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"hep29172-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","year":"1987","journal-title":"J Chronic Dis"},{"key":"hep29172-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0168-8278(03)00088-6","article-title":"Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?","volume":"38","year":"2003","journal-title":"J Hepatol"},{"key":"hep29172-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"hep29172-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2010.06.014","article-title":"A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization","volume":"112","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"hep29172-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins reduce interleukin\u20106\u2010induced C\u2010reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins","volume":"25","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"hep29172-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2014.08.013","article-title":"Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"hep29172-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cvr\/cvn007","article-title":"Simvastatin has an anti\u2010inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel\u2010like factor 2","volume":"78","year":"2008","journal-title":"Cardiovasc Res"},{"key":"hep29172-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.20031132","article-title":"KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation","volume":"199","year":"2004","journal-title":"J Exp Med"},{"key":"hep29172-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial\u2013stellate cell deactivation induced by statins","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep29172-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","year":"2015","journal-title":"Gut"},{"key":"hep29172-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.22916","article-title":"Statins potentiate the in vitro anti\u2010hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep29172-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1572-0241.2008.01876.x","article-title":"Fluvastatin inhibits hepatitis C replication in humans","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep29172-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti\u2010HCV profiles of statins and their potential for combination therapy with interferon","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep29172-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.gastro.2010.08.055","article-title":"Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","article-title":"3\u2010hydroxy\u20103\u2010methylglutaryl\u2010coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis","volume":"122","year":"2002","journal-title":"Gastroenterology"},{"key":"hep29172-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jcb.22092","article-title":"Statins, stem cells, and cancer","volume":"106","year":"2009","journal-title":"J Cell Biochem"},{"key":"hep29172-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.29172","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201709000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:29:36Z","timestamp":1729193376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201709000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.29172","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727423169.793545260","asserted-by":"object"}]},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"assertion":[{"value":"2016-10-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}